BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 19186029)

  • 1. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy.
    Holtman L; van Vliet EA; van Schaik R; Queiroz CM; Aronica E; Gorter JA
    Epilepsy Res; 2009 Mar; 84(1):56-66. PubMed ID: 19186029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.
    Polascheck N; Bankstahl M; Löscher W
    Exp Neurol; 2010 Jul; 224(1):219-33. PubMed ID: 20353773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy.
    Holtman L; van Vliet EA; Edelbroek PM; Aronica E; Gorter JA
    Epilepsy Res; 2010 Sep; 91(1):49-56. PubMed ID: 20643531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
    van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
    Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy?
    Nissinen J; Lukasiuk K; Pitkänen A
    Hippocampus; 2001; 11(3):299-310. PubMed ID: 11769311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy.
    Pitkänen A; Nissinen J; Nairismägi J; Lukasiuk K; Gröhn OH; Miettinen R; Kauppinen R
    Prog Brain Res; 2002; 135():67-83. PubMed ID: 12143371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy.
    Ravizza T; Gagliardi B; Noé F; Boer K; Aronica E; Vezzani A
    Neurobiol Dis; 2008 Jan; 29(1):142-60. PubMed ID: 17931873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
    van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
    Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
    Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
    Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat.
    Holtman L; van Vliet EA; Appeldoorn C; Gaillard PJ; de Boer M; Dorland R; Wadman WJ; Gorter JA
    Epilepsy Res; 2014 Mar; 108(3):396-404. PubMed ID: 24556423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin reduces epileptogenic processes following status epilepticus.
    Chu K; Jung KH; Lee ST; Kim JH; Kang KM; Kim HK; Lim JS; Park HK; Kim M; Lee SK; Roh JK
    Epilepsia; 2008 Oct; 49(10):1723-32. PubMed ID: 18479396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy.
    Rao MS; Hattiangady B; Reddy DS; Shetty AK
    J Neurosci Res; 2006 May; 83(6):1088-105. PubMed ID: 16493685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tolerance to levetiracetam in rats with chronic epilepsy.
    van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
    Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreases in HCN mRNA expression in the hippocampus after kindling and status epilepticus in adult rats.
    Powell KL; Ng C; O'Brien TJ; Xu SH; Williams DA; Foote SJ; Reid CA
    Epilepsia; 2008 Oct; 49(10):1686-95. PubMed ID: 18397293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats.
    Ma L; Cui XL; Wang Y; Li XW; Yang F; Wei D; Jiang W
    Brain Res; 2012 Aug; 1469():103-13. PubMed ID: 22765917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat.
    Goffin K; Nissinen J; Van Laere K; Pitkänen A
    Exp Neurol; 2007 Jun; 205(2):501-5. PubMed ID: 17442304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts.
    Sloviter RS
    Epilepsia; 2008 Dec; 49 Suppl 9():85-92. PubMed ID: 19087122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus.
    Jung KH; Chu K; Lee ST; Kim J; Sinn DI; Kim JM; Park DK; Lee JJ; Kim SU; Kim M; Lee SK; Roh JK
    Neurobiol Dis; 2006 Aug; 23(2):237-46. PubMed ID: 16806953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic changes in the lateral and basal amygdaloid nuclei in temporal lobe epilepsy: an in vitro study in epileptic rats.
    Niittykoski M; Nissinen J; Penttonen M; Pitkänen A
    Neuroscience; 2004; 124(2):269-81. PubMed ID: 14980378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.